article thumbnail

Natco Pharma Limited -Walk-In Interview for Formulation Research & Development (OSD & Injectable) On 4th Feb’ 2023

Pharma Pathway

Candidate should have exposure in handling various dosage forms such as tablets and capsule (ER/ SR IR) / Injectables (Cytotoxic / High potent molecules /drug device combination products) Development of Formulation for ANDA and other regulatory submissions. Our focus is primarily on niche therapeutic areas and complex products.

Dosage 59
article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

Subscribe on iTunes , Android , or Stitcher If you navigate to the page on the website for the Institute for Safe Medication Practices that once hosted the document titled “Oral Dosage Forms That Should Not Be Crushed” you will instead find a notice that the list has been removed from the ISMP website.

Dosage 52
article thumbnail

FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards

Quality Matters

While the FDA has not yet received reports of eye infections associated with these 29 products, the agency published a draft guidance in October 2023 titled “ Quality Considerations for Topical Ophthalmic Drug Products ,” marking the first instance of the FDA providing specific guidance for this product category.

article thumbnail

Understanding GFI #256: The 4 Takeaways That Matter to Your Veterinary Practice

epicur

The FDA recently finalized regulatory guidance for compounded animal medications from bulk drug substances for use in non-food-producing animals, impacting the way compounded drugs can be used, documented, ordered, and prescribed. Pharmacists must document why an FDA-approved or indexed product is not being used to compound the medication.

article thumbnail

Six steps process to implement change control management

GMPSOP

Six steps process to implement change control management Pharmaceuticals quality assurance & validation procedures GMPSOP Six steps process to implement change control management Last modified: June 3, 2023 Table of Contents “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change”.

article thumbnail

Six steps process to implement change control management

GMPSOP

Six steps process to implement change control management Pharmaceuticals quality assurance & validation procedures GMPSOP Six steps process to implement change control management Last modified: May 28, 2023 Table of Contents “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change”.